Narges Alipanah-Lechner, MD, MAS, is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine at UCSF. She earned her undergraduate degree from Johns Hopkins University and completed both her medical degree and master’s degree in clinical and epidemiological research at UCSF.

Dr. Alipanah-Lechner’s research focuses on metabolomics and complementary systems biology approaches within precision medicine to improve diagnosis and treatment of patients with critical illness syndromes.  During her post-doctoral fellowship in Dr. Carolyn Calfee’s laboratory, she discovered novel subtypes of severe COVID-19 pneumonia and identified metabolic differences between ARDS molecular phenotypes.

She currently leads the biology committee of the PANTHER Trial, the first international platform trial utilizing precision medicine in ARDS and was awarded the American Society for Clinical Investigation’s 2024 Emerging Generation Award. In addition to her research, Dr. Alipanah-Lechner provides clinical care in the medical and neurological intensive care units at UCSF.